文献速递肝病

用脂肪性肝病框架重新分类儿童NAFLD:NASH CRN多中心回顾性研究

Reclassifying pediatric NAFLD using the steatotic liver disease framework: A multicenter retrospective study from the NASH CRN.
PubMed 文献 · Hepatology · 2025-10-17

近六分之一患儿因酒精使用或药物暴露被重新分类,提示需系统评估代谢风险、酒精及药物性肝损伤。

要点

  • 1019例儿童NAFLD中84%符合MASLD标准,平均心脏代谢风险因素2.7±1.1个。
  • 3.2%重新分类为Met-ALD,青少年中升至5.4%;6.5%为药物性脂肪性肝病。
  • 儿童NAFLD诊断需系统评估代谢风险、酒精使用及药物暴露。

核心结论

  • 多数儿童NAFLD符合MASLD标准,但近六分之一因酒精使用或药物暴露被重新分类。

研究设计与样本

  • 多中心回顾性研究,纳入NASH CRN中1019例临床诊断NAFLD且有肝活检的儿童,肝活检中心复核确认脂肪变并评估其他病因。

主要发现

  • 858例(84%)符合MASLD标准,平均心脏代谢风险因素2.7±1.1个,41例(4.7%)符合全部五项。

关键数值与推荐

  • MASLD定义为肝脂肪变加至少1项心脏代谢风险因素。
  • Met-ALD定义为MASLD且酒精摄入低于酒精性肝病(ALD)规定阈值。

临床怎么用

  • 儿童NAFLD诊断应系统评估代谢风险因素、酒精使用及药物相关肝损伤,以准确分类并指导管理。

局限性

  • 回顾性设计,仅纳入有肝活检的NASH CRN参与者,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The terminology for hepatic steatosis and NAFLD was revised under the umbrella of steatotic liver disease, with metabolic dysfunction-associated steatotic liver disease (MASLD) as the primary subtype. MASLD is defined by hepatic steatosis plus at least 1 cardiometabolic risk factor. A new category, Met-ALD, describes MASLD with alcohol consumption below the defined thresholds for alcohol-associated liver disease (ALD). While adult studies have demonstrated strong concordance between NAFLD and MASLD, the applicability of this framework in children remains unclear. APPROACH AND RESULTS: We assessed children clinically diagnosed with NAFLD and enrolled in the NASH CRN who had available liver histology. Clinical and demographic data, including body mass index, hepatotoxic medication use, and alcohol intake, were analyzed. Liver biopsies were centrally reviewed to confirm hepatic steatosis and evaluate for alternative etiologies. Participants were reclassified using the steatotic liver disease framework. Among 1019 children diagnosed with NAFLD, 858 (84%) met MASLD criteria. The average number of cardiometabolic risk factors per participant was 2.7±1.1; 41 (4.7%) met all five. Thirty-three participants (3.2%) were reclassified as Met-ALD, a prevalence that rose to 5.4% among adolescents. Sixty-six children (6.5%) were reclassified as drug-induced steatotic liver disease. CONCLUSIONS: Most children with NAFLD met MASLD criteria, but nearly 1 in 6 were reclassified based on alcohol use or medication exposure. These findings highlight the need for a systematic diagnostic approach accounting for metabolic risk factors, alcohol use, and medication-related liver injury.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Lam TBN, Yates KP, Noon SL, et al. Reclassifying pediatric NAFLD using the steatotic liver disease framework: A multicenter retrospective study from the NASH CRN. Hepatology. 2025. PMID: 41104541. doi:10.1097/HEP.0000000000001577

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。